By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
LATEST POSTS
- 1
23 Most Amusing Messages At any point Sent Among Youngsters and Their Folks - 2RFK Jr.’s vaccine advisers plan biggest change yet to childhood schedule
- 3Chicago reports first rabies-positive dog in 61 years. What we know.
- 4Why screening for the deadliest cancer in the U.S. misses most cases
- 5The most effective method to Recuperate After a Dental Embed Strategy: A Far reaching Guide
- The Most Encouraging New companies to Look Out For
- Home Mechanization Frameworks for Brilliant Residing
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- South America's Memorable Destinations: A Movement Guide
- Doctors seek to understand why quitting antidepressants causes withdrawal for some
- Share your pick for the riding area that characterizes your surf undertakings!
- Saturn shines with the waxing moon at sunset on Nov. 29
- Machado ‘presented’ her Nobel Peace Prize medal to Trump
- Building a Maintainable Closet: Individual Excursions in Moral Style
